Friday - DXS International PLC (AQSE: DXSP), a provider of healthcare information and digital clinical decision support systems, has announced its Annual General Meeting (AGM) will be held on December 19, 2024. The meeting is set to take place at noon at Elm House, Tanshire Park, Shackleford Road, Elstead, Surrey GU8 6LB.
Shareholders are directed to the Notice of Annual General Meeting and the AGM Letter for further details, both of which have been distributed to them. These documents, along with the Company's Annual Report for the year ending April 30, 2024, can be downloaded from the DXS International website.
The announcement, which contains information previously classified as inside information under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310, was made with the Directors of DXS International accepting responsibility.
DXS International is known for integrating current treatment guidelines and recommendations from Clinical Commissioning Groups and other reputable NHS sources directly into the workflow of healthcare professionals. This service aims to enhance healthcare outcomes by providing support to doctors, nurses, and pharmacists during patient consultations, thereby contributing to the NHS's efficiency savings goals.
For additional inquiries regarding the AGM, shareholders may contact Claire Louise Noyce from Hybridan LLP, the AQSE Corporate Broker and Corporate Advisor for DXS International.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.